BioSpace News Archive

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today filing of a patent with new data on a unique cell created by the Company capable of training the immune system to kill blood vessels feeding cancer, but sparing healthy blood vessels.

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a specialty pharmaceutical company developing and commercializing critical care drug products, will participate in the virtual Benzinga Biotech Small Cap Conference being held March 24-25, 2021

Procare LTC, a leading pharmacy provider serving the long-term care and post-acute sector, today announced the acquisition of Allen’s PharmaServ, Inc., a long-term care pharmacy based in Youngstown, Ohio, serving group homes, residential treatment facilities, and residents of other post-acute facilities since 1956.

MediXall Group, Inc., a healthcare solutions provider, introduced the Health Karma Partner Program which was designed to provide additional multi-tiered sales channels for its subsidiary, Health Karma, to deliver its product offerings.

“It is a very exciting time to be in the psychedelic industry, which is undergoing rapid expansion.

GigaGen, a biotechnology company advancing transformative antibody drugs for immune deficiency, infectious diseases, transplant rejection and checkpoint resistant cancers, and a subsidiary of Grifols, announced today that it will present an abstract in a poster session at the 2021 American Association for Cancer Research (AACR) Virtual Annual Meeting, which is being held on April 10-15 and May 17-21.

Antares Pharma and other growing innovators leverage new class of AI technology to provide customers with a true omnichannel experience

Hospital for Special Surgery has become the first hospital in New York State to receive the nation’s highest honor for nursing excellence five times.

MESI mTABLET ABI, device used for early detection of Peripheral Arterial Disease (PAD) by measuring Ankle-Brachial Index (ABI), was cleared for marketing and sales by the Food and Drug Administration in December 2020.

Ariadne Labs today announced the launch of the Precision Population Health initiative.